MeiraGTx Holdings PE Ratio 2017-2021 | MGTX

Current and historical p/e ratio for MeiraGTx Holdings (MGTX) from 2017 to 2021. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. MeiraGTx Holdings PE ratio as of October 26, 2021 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

MeiraGTx Holdings PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2021-10-27 21.45 0.00
2021-06-30 15.50 $-1.42 0.00
2021-03-31 14.43 $-1.65 0.00
2020-12-31 15.14 $-1.54 0.00
2020-09-30 13.24 $-1.41 0.00
2020-06-30 12.52 $-1.54 0.00
2020-03-31 13.44 $-1.48 0.00
2019-12-31 20.02 $-1.67 0.00
2019-09-30 15.95 $-2.13 0.00
2019-06-30 26.88 $-2.42 0.00
2019-03-31 17.23 $-4.08 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.965B $0.016B
MeiraGTx Holdings plc focuses on operating as a holding company for MeiraGTx Limited which operates as a clinical stage gene therapy company. It develops novel gene therapy treatments for inherited and acquired disorders. The company's product pipeline consists of AAV-CNGB3, AAV-CNGA3, AAV-RPE65, AAV-RPGR, AAV-AQP1, AAV-AQP1 and AAV-UPF1 which are in clinical stage. MeiraGTx Holdings plc is based in New York.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.416B 8.62
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.526B 21.21
Biohaven Pharmaceutical Holding (BHVN) United States $9.249B 0.00
Emergent Biosolutions (EBS) United States $2.705B 6.53
Arcus Biosciences (RCUS) United States $2.404B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.873B 0.00
Myovant Sciences (MYOV) United Kingdom $1.831B 0.00
Zymeworks (ZYME) Canada $1.080B 0.00
Ambrx Biopharma (AMAM) United States $0.464B 0.00
SQZ Biotechnologies (SQZ) United States $0.372B 0.00
Enzo Biochem (ENZ) United States $0.161B 15.86